IntelGenX
Horst G. Zerbe (Chairman, CEO & Chairman of Scientific Advisory Board)
Bernd J. Melchers (Independent Director)
J. Bernard Boudreau (Independent Vice Chairman & Lead Director)
Summary
History
IntelGenX was founded in 2006 and is a publicly traded company on the TSX Venture Exchange, trading under the symbol “IGX”. The company has over 10 years of experience in the development of innovative drug delivery systems and product candidates, offering potential major breakthroughs in therapeutic delivery.
Mission
Vision
Key Team
Nadine Paiement (Vice-Chair of Scientific Advisory Board and VP of Research & Development - IntelGenx Corp)
Ludwig Aigner (Member of Scientific Advisory Board)
Barry D. Greenberg (Member of Scientific Advisory Board)
Clemens Mayr (Director)
Mark H. Nawacki (Independent Director)
Serge Gauthier (Member of Scientific Advisory Board)
Srinivas G. Rao (Director)
Frank Stegert (Director)
Monika Trzcinska (Independent Director)
Recognition and Awards
References
Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.
Horst G. Zerbe (Chairman, CEO & Chairman of Scientific Advisory Board)
Bernd J. Melchers (Independent Director)
J. Bernard Boudreau (Independent Vice Chairman & Lead Director)
